Danish pharmaceutical giant Novo Nordisk has announced major investment in a French production site to expand the capacity and manufacturing of its blockbuster anti-obesity drug.
Ehhh. I mean, that may be true, but this is for production. I don’t think that the decision to put production in France is necessarily strongly-tied to consumption in-country.
Ehhh. I mean, that may be true, but this is for production. I don’t think that the decision to put production in France is necessarily strongly-tied to consumption in-country.